Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Stroke diagnostics, therapeutics market to reach $31 billion by 2021

A study from Zion Research found that the stroke diagnosis and therapeutics markets has undergone accelerated growth in recent years due to the large patient pool in conjunction with an aging population across the globe. 

Thumbnail

New CMS payment models affect cardiologists, hospitals throughout U.S.

Starting this year, a large number of cardiologists treating fee-for-service Medicare patients will participate in programs in which their reimbursement is tied to providing value-based care. It is the continuation of a trend that many leaders in the healthcare industry believe will become the norm.

Novartis reaches option agreement to license two investigational cardiovascular drugs

Novartis announced on Jan. 6 that it had reached an option agreement with two small pharmaceutical companies to license two investigational cardiovascular medications.

Judge rules Sanofi, Regeneron cannot sell PCSK9 inhibitor in the U.S.

A federal judge in Delaware ruled Jan. 5 that Sanofi and Regeneron Pharmaceuticals could not market or sell their proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor in the U.S.

Federal judge upholds verdict in PCSK9 patent legislation

A federal judge on Jan. 3 upheld an earlier verdict that found Sanofi and Regeneron Pharmaceuticals infringed on two patents developed by Amgen, Reuters reports.

Abbott completes acquisition of St. Jude Medical

Abbott Laboratories completed its acquisition of St. Jude Medical Jan. 4, more than eight months after the companies agreed to the deal.

Cleveland Clinic CEO, heart surgeon turns down Trump’s offer to run VA

Cleveland Clinic CEO Toby Cosgrove, a noted cardiac surgeon, turned down President-elect Donald Trump’s offer to become secretary of the Department of Veterans Affairs (VA), Cleveland.com reports.

GE Healthcare acquires rights to sell cardiovascular stress agent outside North America

GE Healthcare’s life sciences business acquired the rights to produce and sell regadenoson (Rapiscan) in territories outside the U.S., Canada and Mexico.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.